<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-30T17:20:40Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/22856" metadataPrefix="rdf">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/22856</identifier><datestamp>2026-02-03T12:03:22Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37959</setSpec></header><metadata><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:riuma.uma.es:10630/22856">
      <dc:title>Anti-inflammatory potential of aeroplysinin-1, a bioactive compound isolated from the sponge Aplysina aerophoba</dc:title>
      <dc:creator>Bravo-Ruiz, Inés</dc:creator>
      <dc:creator>Bernal, Manuel</dc:creator>
      <dc:creator>Manrique-Poyato, Maria Inmaculada</dc:creator>
      <dc:creator>Rodríguez-Quesada, Ana María</dc:creator>
      <dc:creator>Medina-Torres, Miguel Ángel</dc:creator>
      <dc:creator>Castilla, Laura</dc:creator>
      <dc:creator>Martínez-Póveda, Beatriz Amparo</dc:creator>
      <dc:subject>Medicamentos - Congresos</dc:subject>
      <dc:description>Contribución a Congreso (póster)</dc:description>
      <dc:description>Aeroplysinin-1 (Apl-1) is a brominated compound isolated from the marine sponge Aplysina aerophoba that has been shown to possess bioactive effects with a broad spectrum of action in in vitro and in vivo assays. Included in its pleiotropic activity are anti-tumor, anti-angiogenic, pro-apoptotic [1] and anti-oxidant effects [2], making Apl-1 a natural compound with very promising properties for its use as a potential therapeutic agent. In addition to the aforementioned effects, our group explored the role of Apl-1 in inflammation, a process related to numerous highly prevalent pathologies, such as cancer and atherosclerosis, showing the first evidence of its anti-inflammatory potential [3]. &#xd;
&#xd;
In this work, our group delves into the anti-inflammatory effect of Apl-1 in the context of vascular endothelium and provides new data regarding the molecular mechanism underlying this activity. The characterization of the mechanism of action points to the modulatory effect of Apl-1 on pathways involved in endothelial activation during the development of inflammation, experimental evidence that opens the door to the potential use of this compound as an anti-inflammatory agent.</dc:description>
      <dc:date>2021-09-20T09:50:41Z</dc:date>
      <dc:date>2021-09-20T09:50:41Z</dc:date>
      <dc:date>2021</dc:date>
      <dc:date>2021</dc:date>
      <dc:type>conference output</dc:type>
      <dc:identifier>https://hdl.handle.net/10630/22856</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:relation>43 Congreso Anual de la Sociedad Española de Bioquímica y Biología Molecular</dc:relation>
      <dc:relation>Barcelona</dc:relation>
      <dc:relation>Julio 2021</dc:relation>
      <dc:rights>open access</dc:rights>
      <dc:publisher>43 Congreso Anual SEBBM</dc:publisher>
   </ow:Publication>
</rdf:RDF>
</metadata></record></GetRecord></OAI-PMH>